1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Fractyl Health said Nasdaq notified it on September 10, 2026 that its stock is subject to delisting because it did not regain compliance with the $1.00 minimum bid price requirement by September 9, 2026. The company intends to request a hearing before a Nasdaq Hearings Panel, which would keep its stock listed while the process runs, and has proposed a reverse stock split of 1-for-5 to 1-for-15 for stockholder approval.
Nasdaq letter dated September 10, 2026 says the stock is subject to delisting unless the company timely requests a hearing
Company did not meet the $1.00 minimum bid price within the 180-calendar day grace period ending September 9, 2026
Company intends to request a Panel hearing, which automatically stays suspension or delisting
Proxy statement filed August 24, 2026 seeks approval for a reverse split ranging from 1-for-5 to 1-for-15
Greenland Technologies Holding received a Nasdaq letter on September 10, 2026, granting an additional 180-day period, until March 8, 2027, to regain compliance with the $1.00 minimum bid price. The company says the letter has no immediate impact on its listing, but its Class A shares must still close at or above $1.00 for 10 consecutive business days, and failure to do so would lead to a delisting notice.
Nasdaq letter dated September 10, 2026 extends the compliance deadline from September 8, 2026 to March 8, 2027
Shares must close at or above $1.00 for at least 10 consecutive business days, which may be extended to 20 at Nasdaq's discretion
The company may effect a reverse stock split if necessary to cure the deficiency
If compliance is not regained, Nasdaq will issue a delisting notice, which the company could appeal to a hearings panel
SI-BONE initiated a voluntary recall on August 21, 2026, of 98 iFuse TORQ implants from specific lots because some tube packaging may not meet sterile-barrier criteria. The company expects a gross charge of up to approximately $150,000 in third and fourth quarter cost of goods sold, and says it does not expect third quarter revenue to be otherwise affected. Separately, the company extended its Santa Clara headquarters lease for October 2026 at $43,696 per month.
Recall covers 98 implants from specific lots; tube packaging was made between May 4 and May 15, 2026.
Two recalled implants were already used in patients; no infections or adverse events reported as of the filing date.
About 3,900 implants need repackaging and re-sterilization; up to approximately $150,000 gross charge expected in Q3 and Q4 cost of goods sold.
FDA was notified on August 31, 2026, and the company recommends a Class II classification; the Fourth Lease Amendment runs October 1 to October 31, 2026.
Cardlytics agreed on September 4, 2026 to settle a claim by Amit Jain, former Bridg founder and CEO, for $6.4 million, covering his share of a California settlement and related legal fees. The amount matches the $6.5 million the company had already accrued as of June 30, 2026, so the filing describes no new charge, and the company says it is seeking insurance reimbursement.
Settlement agreement dated September 4, 2026 resolves Jain's claim for $6.4 million in total.
The total includes $5.3 million for his allocated portion of the DailyGobble Action settlement and $1.1 million in legal fees.
The amount is consistent with the $6.5 million accrual recorded as of June 30, 2026.
Cardlytics is seeking insurance reimbursement for some of the costs.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.